Skip to content

molecular design & engineering

Impressum
Privacy Policy
Projects
Publications
Welcome

Search for:

2021-04-242021-10-19

Large Molecules 2020

Uncategorized by Lutz Weber

2020 Large Molecule Drug Approvals

Post navigation

New ADC approval

Posts

Novel targeted E7 protein degraders 2022-10-24
Anixa-MolGenie compounds are more potent than the protease inhibitor in Pfizer’s PAXLOVID™ at inhibiting the main protease of SARS-CoV-2 2022-01-27
Anixa Biosciences and MolGenie Announce that their COVID-19 Compounds are Expected to be Effective Against the Omicron Variant 2021-12-23
Good news for small molecule SARS-CoV-2 virus inhibitors: Pfizer demonstrates clinical efficacy! 2021-11-05
Anixa Biosciences’ Covid-19 Compounds Expected to be Effective Against the Delta Variant 2021-08-26

Archives

October 2022
January 2022
December 2021
November 2021
August 2021
June 2021
May 2021
April 2021

Novel targeted E7 protein degraders
Anixa-MolGenie compounds are more potent than the protease inhibitor in Pfizer’s PAXLOVID™ at inhibiting the main protease of SARS-CoV-2
Anixa Biosciences and MolGenie Announce that their COVID-19 Compounds are Expected to be Effective Against the Omicron Variant
Good news for small molecule SARS-CoV-2 virus inhibitors: Pfizer demonstrates clinical efficacy!
Anixa Biosciences’ Covid-19 Compounds Expected to be Effective Against the Delta Variant

Proudly powered by WordPress | Theme: Airi by aThemes.

Consent Management Platform by Real Cookie Banner